HCG completes transaction under BTA, SSA with Strand Life Sciences

10 Feb 2018 Evaluate

Healthcare Global Enterprises (HCG) has concluded the transactions under the Business Transfer Agreement (BTA) and the Share Subscription Agreement (SSA) entered with Strand Life Sciences. Further, Strand Life Sciences has received investments from Taurus QC Investment Holdings and Healthquad Fund I; and the shareholding of the company in Strand Life Sciences stands at 38.2% on a fully diluted basis.

Earlier in January, HCG had entered into definitive agreements providing for a business combination of its Triesta Sciences business unit (Triesta Sciences), with Strand Life Sciences, a company incorporated under the Companies Act, 1956. The company had entered into a BTA, a SSA and a Shareholders’ Agreement (SHA) with Strand Life Sciences in relation to the proposed Business Combination.

HealthCare Global Enterprises is the largest provider of cancer care in India. Through its network of 15 comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.

HealthcareGlobal Share Price

631.05 4.25 (0.68%)
22-Jan-2026 13:45 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6798.65
Max Healthcare Inst 994.70
Narayana Hrudayalay 1766.90
Aster DM Healthcare 571.35
Global Health 1065.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×